Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study

<p><strong>Background:</strong> Melioidosis is a neglected but often fatal tropical disease. The disease has broad clinical manifestations, which makes diagnosis challenging and time consuming. To improve diagnosis, we aimed to evaluate the performance of the CRISPR-Cas12a...

Full description

Bibliographic Details
Main Authors:	Pakdeerat, S, Boonklang, P, Angchagun, K, Chomkatekaew, C, Apichaidejudom, N, Dokket, Y, Faosap, A, Wongsuwan, G, Wuthiekanun, V, Aramrueung, P, Khamnoi, P, Thananchai, H, Siriboon, S, Chamnan, P, Peacock, SJ, Day, NPJ, Thomson, NR, Uttamapinant, C, Wongpalee, SP, Chewapreecha, C
Format:	Journal article
Language:	English
Published:	Elsevier 2024

Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study

Similar Items